Review article · 2003

Tyrosine kinases as targets in cancer therapy - successes and failures

Peter M. Traxler

Expert Opinion on Therapeutic Targets, 7(2), 215–234 · Published 1 January 2003 · DOI 10.1517/14728222.7.2.215

View at the publisherCite this paper

In brief

“Tyrosine kinases as targets in cancer therapy - successes and failures” is a 2003 review article by Peter M. Traxler, published in Expert Opinion on Therapeutic Targets. OpenAlex counts 246 citations as of 21 November 2026, which puts it in the top 6% of works published in 2003 by citations. The publisher's version is not open access, and OpenAlex records no free legal copy.

Citations
246
Most cited in
2023 (14)
Field-weighted impact
1.80
References
144
Authors
1

Abstract

Protein kinases play a crucial role in signal transduction and also in cellular proliferation, differentiation and various regulatory mechanisms. The inhibition of growth-related kinases, especially tyrosine kinases, might therefore provide new therapies for diseases such as cancer. Due to the enormous progress that has been made in the past few years in the identification of… Read the full abstract at the publisher.

Excerpt. This paper is not open access.

Cite this paper

Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.

APA 7

Traxler, P. M. (2003). Tyrosine kinases as targets in cancer therapy - successes and failures. Expert Opinion on Therapeutic Targets, 7(2), 215–234. https://doi.org/10.1517/14728222.7.2.215

MLA 9

Traxler, Peter M. “Tyrosine kinases as targets in cancer therapy - successes and failures.” Expert Opinion on Therapeutic Targets, vol. 7, no. 2, 2003, pp. 215–234. https://doi.org/10.1517/14728222.7.2.215.

Chicago

Traxler, Peter M. 2003. “Tyrosine kinases as targets in cancer therapy - successes and failures.” Expert Opinion on Therapeutic Targets 7 (2): 215–234. https://doi.org/10.1517/14728222.7.2.215.

Harvard

Traxler, P. M. (2003) ‘Tyrosine kinases as targets in cancer therapy - successes and failures’, Expert Opinion on Therapeutic Targets, 7(2), pp. 215–234. doi:10.1517/14728222.7.2.215.

IEEE

P. M. Traxler, “Tyrosine kinases as targets in cancer therapy - successes and failures,” Expert Opinion on Therapeutic Targets, vol. 7, no. 2, pp. 215–234, 2003, doi: 10.1517/14728222.7.2.215.

BibTeX

@article{traxler2003tyrosine,
  title     = {{Tyrosine kinases as targets in cancer therapy - successes and failures}},
  author    = {Traxler, Peter M.},
  journal   = {Expert Opinion on Therapeutic Targets},
  year      = {2003},
  volume    = {7},
  number    = {2},
  pages     = {215--234},
  doi       = {10.1517/14728222.7.2.215},
  url       = {https://doi.org/10.1517/14728222.7.2.215}
}

Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)

Citations by year

YearCitationsShare of the best year
20171212
201866
201999
202066
202177
202288
20231414
20241212
202533
202622

Its field-weighted citation impact is 1.80: it has been cited 1.80 times as often as the average work of the same field, type and year (1.00 is the world average).

Topic and keywords

Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer Mechanisms and Therapy

  • tyrosine kinase inhibitors
  • cancer therapy
  • ATP-binding domain
  • rational drug design
  • epidermal growth factor receptor
  • vascular endothelial growth factor receptor
  • platelet-derived growth factor receptor
  • KIT

Work with this paper

Most-cited papers in Biochemistry, Genetics and Molecular Biology

All highly cited Biochemistry, Genetics and Molecular Biology papers

Questions about this paper

How do I cite this paper in APA style?

Traxler, P. M. (2003). Tyrosine kinases as targets in cancer therapy - successes and failures. Expert Opinion on Therapeutic Targets, 7(2), 215–234. https://doi.org/10.1517/14728222.7.2.215

How many times has this paper been cited?

246 times, according to OpenAlex on 21 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.

Is this paper free to read?

OpenAlex records no free legal copy. Check your library's access, the authors' pages or a repository, or ask the corresponding author for a copy.

Who wrote this paper?

Peter M. Traxler.

What is the DOI of this paper?

10.1517/14728222.7.2.215, permanently at https://doi.org/10.1517/14728222.7.2.215. Sign in and open it from this page.

Bibliographic data from OpenAlex (CC0), last checked 21 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.